December 15, 2025 Deadline Approaching: Join Class Action Against Baxter International, Inc. (BAX) - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - November 17, 2025) - If you suffered a loss on your Baxter International, Inc. (NYSE: BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-fo ...

or contact Joseph E. Levi, Esq. via email at [e-mail] or call [phone] to speak to our team of experienced shareholder advocates.

Cannot view this video? Visit:
https://www.youtube.com/watch?v=q-KEhS5vJYs

THE LAWSUIT: A class action securities lawsuit was filed against Baxter International, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between February 23, 2022 and July 30, 2025.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (a) Baxter's recently launched product, the Novum LVP, suffered systemic defects that caused widespread malfunctions, including underinfusion, overinfusion, and complete non-delivery of fluids, which exposed patients to risks of serious injury or death; (b) Baxter was notified of multiple device malfunctions, injuries, and deaths from these defects; (c) Baxter's attempts to address these defects through customer alerts were inadequate remedial measures, when design flaws persisted and continued to cause serious harm to patients; (d) as a result, there was a heightened risk that customers would be instructed to take existing Novum LVPs out of service and that Baxter would completely pause all new sales of these pumps; and (e) based on the foregoing, Baxter's statements about the safety, efficacy, product rollout, customer feedback and sales prospects of the Novum LVPs were materially false and misleading.

WHAT'S NEXT? If you suffered a loss in Baxter International, Inc. stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-fo ... to learn about your rights to seek a recovery. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[e-mail]
Tel: [phone]
Fax: [phone]
https://zlk.com/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274770

The Baxter International Stock at the time of publication of the news with a raise of +0,63 % to 16,00EUR on Tradegate stock exchange (17. November 2025, 13:00 Uhr).